The role of adrenergic agents in augmenting proximal tubular salt and water flux, was studied in a preparation of freshly isolated rabbit renal proximal tubular cells in suspension. Norepinephrine (NE, 10-5 M) increased sodium influx (JNa) 60±5% above control value. The alpha adrenergic antagonist, phentolamine (10-5 M), inhibited the NE-induced enhanced JNa by 90±2%, while the beta adrenergic antagonist, propranolol, had a minimal inhibitory effect (10±2%). The alpha adrenergic subtype was further defined. Yohimbine (10-5 M), an alpha2 adrenergic antagonist but not prazosin (10-5 M), an alpha, adrenergic antagonist completely blocked the NE induced increase in JN.. Clonidine, a partial alpha2 adrenergic agonist, increased JNS by 58±2% comparable to that observed with NE (10-5 M). Yohimbine, but not prazosin, inhibited the clonidine-induced increase in JN., confirming that alpha2 adrenergic receptors were involved. Additional alpha2 adrenergic agents, notably p-amino clonidine and alpha-methyl-norepinephrine, imparted a similar increase in JN.. The clonidineinduced increase in JNS could be completely blocked by the amiloride analogue, ethylisopropyl amiloride (EIPA, 10'-M). sites/cell and KD 5.4±1.4 nM. In summary, in the isolated rabbit renal proximal tubular cell preparation, alpha2 adrenergic receptors are the predominant expression of alpha adrenoceptors, and in the absence of organic Na'-cotransported solutes, alpha2 adrenergic agonists enhance 22Na influx into the cell by stimulating the brush border membrane Na'-H' exchange pathway.
Introduction
There is general agreement that catecholamines are antinatriuretic. Both data obtained in whole animal experiments or performed on the isolated perfused kidney tend to support this view (1) (2) (3) (4) . The enhanced rate of catecholamine-induced solute flux across the tubular epithelial cell is attributed primarily to alpha adrenergic agonist activity. Both alpha, and alpha2 adrenergic receptors have been invoked (3, 4) . However, these types of experiments cannot discern whether the observed change in sodium excretion is exclusively a direct consequence of catecholamine action on renal tubular transport, or an indirect consequence ofsome other action ofthe agent, e.g., hemodynamic alterations.
The bulk of the early experimental data dealing with the specificity of the subtypes of adrenergic receptors present on the renal tubule, have been derived essentially by indirect methods. The renal adrenoceptors have been studied by examination of the end-organ response after administration of selective agonists and antagonists (5, 6) . Alternately, renal nerves have been electrically excited and similar pharmacological maneuvers performed (1) . While this type of approach ensures that the receptors are pharmacologically relevant, it is difficult to pinpoint with any certainty their anatomical distribution within the organ. The subsequent use of radioligand assays to characterize adrenergic receptor subtypes, has proven to be an extremely powerful tool.
This study describes the effect of adrenergic agents on a membrane transport event, and correlates these findings with radioligand binding studies in the same preparation, the intact rabbit renal proximal tubular cell. The results demonstrate that in this preparation, alpha2 adrenergic receptors are the predominant adrenergic subtype, and that in the absence of Na'-cotransported solutes, alpha2 adrenergic agonists enhance 22Na influx into the cell by stimulation of the brush border membrane Na'-H' exchange pathway.
Methods
Isolation ofproximal tubular cells. A suspension of isolated proximal tubular cells was prepared from rabbit kidney as previously described (7) . Briefly, the kidneys were perfused with a modified Hanks' solution comprised of (in mM): NaCl 137, KC1 3, CaCl2 2, MgCl2 0.5, MgSO4 0.4, KH2PO4 0.5, Na2HPO4 0.3, -glucose 5, L-lactate 4, L-alanine 1, Tris HC 5, and Tris base 6 titrated to pH 7.4 to which BSA 0.2% (wt/vol) was added. The blanched kidneys were perfused with 2 ml of the above solution containing 0.5% (wt/vol) iron oxide. The large magnetized iron particles are trapped in the glomerular capillary network. The cortex was dissected from the medulla, homogenized, and passed sequentially through a 250-,gm and 80-,gm nylon mesh screen. The proximal tubules and glomeruli, trapped on the 80-am mesh, were suspended in the preparative medium, and the iron-laden glomeruli were extracted with a magnet. The proximal tubule suspension was briefly exposed to a hypotonic medium (75 mM) devoid of divalent cations, and mechanically agitated for 60-90 s. Total exposure time to the hypotonic medium was < 2 min. After resuspension in the preparative medium, the suspension was passed through additional nylon meshes and glass wool to remove contaminating tubule fragments. The final cell pellet was suspended in a medium the composition of which was determined by the specific experimental condition. Cell counts were obtained by counting appropriate dilutions ofcell suspension in a standard hemocytometer chamber. A typical two kidney preparation yielded 5-6 X 108 cells, and was completed in 50-60 min. Characterization of the cell suspension as being predominantly of proximal tubule origin, and the functional integrity of the preparation, have previously been described (7) .
Transport experiments. Transport experiments with 22Na' to monitor sodium influx (JNa)1 into cells, were performed at 370C using a rapid filtration procedure (8) . Freshly prepared cells were preequilibrated for 20 min at 370C in a sodium-free buffer comprised of (in mM): tetramethylammonium chloride (TMA-Cl) 55, KCl 80, CaC12 2, MgCl2 1, titrated to pH 7.4 with Tris-base 7.7 and Hepes 12.3 (final osmolarity 296 mosM); 10-4 M ouabain was added to the solution. Previous experiments have established that intracellular pH (pH1) is 7.30-7.35 following incubation under these conditions (7) . The transport buffer (370C) was identical to the equilibration buffer except that 55 mM NaCl replaced TMA-CI isoosmotically. This concentration of Na' was chosen since the amiloride analogue could inhibit JNa+ by at least 50% vs. 10-20% at 140 mM Na'. Ouabain (l0-4 M) and 1.5 MCi tracer-free 22Na' were added to the transport buffer. Where indicated, a 1: 1,000 dilution of catecholamine (agonist, antagonist, or both) was added to the transport buffer alone. In experiments where norepinephrine was used, the compound was suspended in a l0-3 M ascorbic acid solution immediately before use. Preliminary experiments showed that ascorbic acid had no effect on JNa. In experiments where the amiloride analogue ethylisopropyl amiloride (EIPA) was used, the probe was added to the transport buffer in a 1:1,000 dilution. EIPA (7) .
After incubation with the isotope, the cell suspension was pipetted onto 400 Ml of silicon oil mixture consisting of (vol/vol) 80% silicone oil (SG 1.504) and 20% US Pharmacopeia medium mineral oil, and rapidly pelleted in a microfuge. The supernatant was removed, pH determined, and an aliquot taken for determination of radioactivity. The microfuge tube and its remaining contents were immersed in liquid nitrogen (-190 (7), and use of an intact cell rather than membrane fragments, increased the nonspecific component of radioligand binding.
Freshly prepared cells were pelleted at 600 g, washed twice, and resuspended in binding buffer, comprised of (in mM): NaCl 120, EDTA 0.5 and Tris-HCl 50, titrated to pH 7.5. The radioligand binding studies were performed using this buffer. Assays for estimation of receptor number were conducted in a total volume of 250 gl, and competitive binding studies were conducted in a total volume of 500 Ml. Intact cells were incubated with the specific ligands for 1 h at 25°C in a shaking water bath. Preliminary experiments established that equilibrium binding conditions for proximal tubule cells were similar to that described for other tissues (10) . Reactions were terminated by dilution with 10 ml of ice-cold buffer containing (in mM): EDTA 0.5, Tris-HCl 50, titrated to pH 7.5. The stopped reaction was immediately passed over glass fiber filters (Whatman, GF/C) that were washed with an additional 10 ml ofthe chilled buffer. The radioactivity retained on the filters was determined by liquid scintillation spectometry. Statistical analysis. Differences in JNa were assessed by one or two way analysis of variance, (ANOVA) as appropriate (1 1 by the amiloride analogue EIPA (10-5 M) . In these experiments, EIPA inhibited JNa by 48±2% (P < 0.0001) and inhibited the clonidine-induced increase in JNa by 95±4% (P <0.0001). Similar results were obtained for NE (data not shown) and have been previously demonstrated for another alpha2 adrenergic agonist, guanabenz (14).
The effect of different concentrations of clonidine (10-10 M-10-5 M) on antiport activity was tested and the results are illustrated in Fig. 5 . No response was elicited at 1010 M or 10-9 M clonidine. At the highest concentration of alpha2 agonist tested (10' M), JNa reached a maximal value, although a peak value was not attained. This precluded accurate determination of the K0.5 for clonidine for the process.
Since high concentrations of a compound-like clonidine may also bind to alpha, receptors (13), clonidine-stimulated JNa was tested in the presence of prazosin and yohimbine, specific alpha, and alpha2 adrenergic receptor antagonists, respectively ( were not different from control values: control 0.49±0.06 vs. yohimbine 0.46±0.01 vs. prazosin, 0.60±0.02 nmol 106 cells 3 min. In three experiments, JNa was increased 5±2% and 8±3% in the presence of yohimbine and prazosin, respectively (NS). In the experiment depicted in Fig. 6 , yohimbine, the alpha2 antagonist, blocked the clonidine-stimulated JNa by 82%: clonidine 0.99±0.02 vs. clonidine + yohimbine 0.58±0.01 nmol* 106 cells * 3 min. Prazosin, the alpha1 antagonist, was a poor inhibitor of clonidine-stimulated JNa : clonidine 0.99±0.02 vs. clonidine + prazosin 0.87±0.01 nmoI 106 cells * 3 min (24%). The mean inhibitory effect ofyohimbine or prazosin on clonidine-stimulated JNa in three experiments was 87±6% (P < 0.005) and 20±3% (NS), respectively. The concentration of prazosin used in these experiments has been documented to interact partially with alpha2 adrenergic receptors, but is several orders of magnitude higher than that required to block fully alpha, adrenergic receptors (14).
Additional alpha2 agonists were tested to demonstrate that alpha2 agonist JNa+ stimulation was not confined to clonidine alone. Fig. 7 shows that in addition to clonidine, p-aminoclonidine and alpha-methyl-NE stimulate JNa in a comparable manner. The mean stimulatory effect observed in three experiments was 58+2%, 60+5%, and 70±8% for clonidine, pamino-clonidine, and alpha-methyl-NE, respectively (P <0.0001). Other data indicate that the partial alpha2 adrenergic agonist, guanabenz, shows this effect (15) . Control Exclusion ofalternate processes that might enhance alpha2 adrenergic induced increase in sodium influx. The alpha2 adrenergic enhanced JNa observed in the absence of sodiumcotransported solutes, and inhibition of this process by the amiloride analogue EIPA, is consistent with alpha2 adrenergic stimulation of Na+-H+ antiport. It is feasible, however, that under the described experimental conditions, the observed increase in JNa may be a secondary effect consequent to other primary events. In this regard, alpha2 adrenergic agonists might conceivably stimulate metabolic processes that would increase proton production rate, thereby secondarily enhancing antiport activity. Alternately, stimulation of a Na'-dependent base exit pathway by alpha2 adrenergic agonists could result in a net increase in 22Na' influx into the cell. Stimulation of a Na+ channel by the catecholamine is a third possibility. Experiments addressing these specific issues are described below. To test whether catecholamines increased proton production rate, cells preequilibrated in the 55 mM NaCl transport buffer in the presence of 10-4 M oubain (see Methods) were exposed to 10-5 M EIPA, NE or clonidine for 3 min under identical experimental conditions described for the transport experiments, and pHi derived using the weak acid distribution method (DMO). In additional experiments, NE and clonidine incubation was performed in the presence of EIPA. Note that preequilibration was performed in the 55-mM NaCl buffer in the presence of oubain, so that exposure of cells to Although scant evidence exits for the presence of a sodium channel in the plasma membrane of the proximal tubule cell in situ, it is feasible that the preparative procedure might unmask such a Na+-entry pathway, and that catecholamines may augment JNa via this mechanism. 3-min 22Na' uptakes in the presence of 10-5 M NE or clonidine were monitored with addition of 10-5 M or 10-7 M EPIA. The catecholamine-induced increase in JNa was completely blocked by 10-' M EIPA (see Fig. 4 ), however 10-7 M EIPA, a concentration that would be expected to block Na+ channels in the distal tubule (17) , was without effect (n = 2). These data render unlikely the possibility that catecholamines impart their effect via stimulation of a Na+ channel.
Radioligand binding studies. Radioligand binding studies using specific probes for alpha, and alpha2 adrenergic recep- (Fig. 9) .
The ability of the amiloride analogue, EIPA, to block Na+ 
Discussion
The present studies demonstrate that in the rabbit renal proximal tubule, alpha2 adrenergic agonists enhance sodium influx into the cell, and that an increase in Na'-H+ antiport activity can account for the increment in sodium uptake. That the alpha2 adrenergic agonist increase in sodium influx was indeed mediated via Na'-H+ antiport activity, is based primarily on the observation that in the absence of Na+-cotransported substrates, the amiloride analogue EIPA, completely inhibited the alpha2 agonist enhanced rate of sodium influx ( Figs. 1 and 4) . Since the affinity of EIPA for the alpha2 adrenergic binding site is 100-fold less than its affinity for the antiporter in this preparation, i.e., 20 ,M (Fig. 9 ) vs. 0.3 IAM when corrected for pH (7), competition between EIPA and alpha2 adrenergic agonist for the adrenoceptor (18) cannot be invoked as a plausible explanation for these observations. Two independent lines of evidence confirm that in preference to other catecholamines, alpha2 adrenergic agonists are functionally the predominant adrenergic subtype in the rabbit renal proximal tubule. First, the flux experiments clearly demonstrate that the NE-enhanced increased rate ofantiport activity was blocked by yohimbine, a specific alpha2 adrenergic antagonist, but not by prazosin, a specific alpha, adrenergic antagonist (Fig. 3) . Furthermore, clonidine, a partial alpha2 adrenergic agonist, enhanced antiport activity, and this effect could be blocked by yohimbine but not prazosin, thereby rendering unlikely the possibility that clonidine may have imparted its effect via alpha, adrenergic receptors (Fig. 6 ). Additional alpha2 adrenergic agonists, p-amino clonidine, alphamethyl-NE (Fig. 7) and guanabenz (14) had similar effects, thereby establishing that the effect of clonidine was shared by several agonists active at the alpha2 adrenergic receptor. Second, radioligand binding studies demonstrated that alpha2 adrenoceptors were the predominant alpha adrenergic receptor in this preparation. In addition, the KD of [3H]rauwolscine for alpha2 adrenergic binding sites (Fig. 8) was 5.4±1.4 nM, a value similar to that reported in membrane preparations from kidneys of rabbit, rat, dog, and mouse (9) . Taken together, the functional studies and radioligand binding data complement one another and provide strong evidence that binding of alpha2 adrenergic agonists to their specific receptors resulted in enhanced Na+-H+ antiport activity.
There is general agreement that at the level of the renal proximal tubule, catecholamines enhance salt and water reabsorption (19-21). However, some species difference may exist in the nature ofthe adrenergic receptor. In vivo micropuncture studies in rat indicate that sodium reabsorption (J.) is effected by alpha adrenergic agonists (16, 17) although in one study ( 17) beta adrenergic agonists were also found to stimulate Jv. In rabbit, however, in vitro microperfusion studies suggest that beta adrenergic agonists stimulate Jv, whereas alpha adrener- (Fig. 2) . The nature of the discrepancy between the current observations and those in the isolated perfused rabbit proximal tubule is not immediately apparent.
Although catecholamines enhance proximal tubule salt and water reabsorption, the stimulated transport pathway whereby sodium crosses the epithelium has hitherto not been described. Since the present studies were performed on a suspension of cells, the paracellular route can obviously be discounted. The observation that the amiloride analogue EIPA (l0-5 M) completely inhibited the catecholamine-induced increase in sodium influx in the absence of Na+-cotransported substrate (Fig. 4) indicates that Na+-H' antiport activity was enhanced. The agonists (NE and clonidine) appear to impart their effect directly on antiport activity and not indirectly by primarily lowering pHi either by stimulation of a base-exit pathway or enhanced proton production accompanying stimulation of intracellular metabolic processes. In support of the observation that catecholamines enhance Na+-H' antiport activity is the report of Chan (16), that alpha adrenergic agonists enhance bicarbonate absorption in rat proximal convoluted tubule. Since bicarbonate reabsorption in this segment is critically dependent upon proton availability in the tubule lumen, and since the major pathway for proton entry into the lumen occurs via exit of H+ from the cells on the Na+-H+ antiporter (22) , stimulation of the exchanger by catecholamines would explain the increase in bicarbonate absorption.
The pharmacological characterization of the adrenoceptor involved in the control of renal tubular sodium handling, has been the subject of increasing attention, but has resulted in conflicting results. With regard to rabbit kidney, Neylon and Summers (9) found specific alpha2 adrenergic binding sites in membrane fragments of renal cortex, with little evidence for alpha, adrenergic sites. Kusano and co-workers (23) using renal tubular fragments from different nephron segments demonstrated that alphaI adrenergic receptors were present on the proximal convoluted tubule (PCT) but not on the proximal straight tubule (PST). The possibility of the presence of alpha2 adrenergic binding sites could not be excluded since only an alpha, adrenergic probe was utilized. Preliminary data by Raymond and co-workers (24) indicates the presence of alpha2 adrenergic receptors in basolateral membranes prepared from purified rabbit tubule segments. No data is provided regarding the alpha1 adrenoceptors. The current studies (Fig. 8) indicate the presence of alpha2 adrenergic binding sites with little evidence for alpha1 adrenergic receptors and complement the findings of Neylon and Summers (9) . Additional experiments will have to be performed on different populations of the proximal cell preparation, to document whether alpha2 adrenergic receptors are confined to a specific cell type.
The current results provide new insights regarding the anatomical localization of alpha2 adrenergic receptors in the renal Alpha2 Agonist Figure 11 . cortex. Autoradiographic studies ofguinea pig (25) and rat ( 14, 26) kidney indicate that alpha2 adrenergic receptors confined to the renal cortex are present on proximal tubules, while in dog the receptors appear to be confined to the vasculature (27). Similar studies on rabbit kidney have, to the best of our knowledge, not been performed. However, this methodology fails to distinguish between receptors present on nerve endings versus tubular cells. Our findings that combine functional and radioligand binding techniques provide strong evidence that proximal tubular cells from rabbit (and we would suspect other species as well) possess alpha2 adrenergic receptors. The overall contribution of these receptors to the total population of alpha2 adrenergic receptors in the kidney will require further studies.
The molecular mechanisms by which alpha2 adrenergic receptors regulate the Na'-H' antiporter in proximal tubule cells has not been defined. At least two possibilities exist (Fig.  1 1) . Work by Limbird and coworkers has suggested that agonist binding to alpha2 adrenergic receptors, at least in human platelets, may enhance Na'-H' antiport activity either via a direct action of the receptor or guanine nucleotide inhibitory protein (Gi) (28) . An alternate explanation would be that alpha2 adrenergic receptor-mediated activation of Gi leads to an inhibition of adenylate cyclase activity, and the resultant decrease in cyclic AMP-dependent protein kinase phosphorylation leads to an enhancement of antiport activity. In this regard, previous evidence indicates that alpha2 adrenergic receptor activation can decrease PTH-stimulated adenylate cyclase activity (29) , and that stimulation ofcyclic AMP in rabbit proximal tubule can exhibit Na'-H' exchange (30) . Since the rabbit proximal tubular cell responds to both parathyroid hormone (7) and alpha2 adrenergic agonists, these cells should provide a useful mode to define further the mechanism whereby several types of hormones modulate Na+-H+ antiport activity.
